Last Friday, BGM announced the acquisition of two AIFU subsidiaries, including the core assets behind the “Du Xiao Bao” platform. BGM, a global pharma and chemicals giant, has been aggressively pivoting toward AI, especially in enterprise-level cost optimization. This acquisition strategically positions BGM in the high-potential insurance and health sectors while aligning with the second phase of AI adoption. The market recognized this bold move, sending BGM shares up over 20% following the announcement.
Nick44444444 : Copy verbatim?
大牛逼 Nick44444444 : I copied the emoji from you
71079603 : Thought it was the alter ego of Mr. Beautiful Investment.
USCY : Do you want a face? Don't write the source and then pretend it's original?